• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴西队列中类肉瘤病病程的预后特征。

Prognostic features of sarcoidosis course in a Brazilian cohort.

机构信息

. Departamento de Pneumologia, Universidade Federal de São Paulo, São Paulo (SP) Brasil.

出版信息

J Bras Pneumol. 2022 Feb 2;48(1):e20210366. doi: 10.36416/1806-3756/e20210366. eCollection 2022.

DOI:10.36416/1806-3756/e20210366
PMID:35137872
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8836631/
Abstract

OBJECTIVE

To identify predictive features associated with the course of sarcoidosis at initial evaluation and to develop a predictive score.

METHODS

This was a retrospective study involving pulmonary sarcoidosis patients, classified as having a self-limited or persistent course of disease, comparing data between the outcomes by univariate analysis. Features related to persistent disease were selected by multivariate analysis and a prognostic score was designed.

RESULTS

The sample comprised 200 patients (mean age = 49 years). The median duration of symptoms to diagnosis was 12 months, and delayed diagnosis (> 12 months) was found in 43% of the cases. The most common radiological stage was II; 37% had reduced FVC. Relevant systemic involvement was detected in 37% of the patients. Treatment for tuberculosis was prescribed in 44 patients prior to sarcoidosis diagnosis. Treatment for sarcoidosis was required in 77% of the sample, and the disease course was persistent in 115 cases. Excluding 40 patients with fibrotic disease, prognostic factors to persistent disease were parenchymal involvement, delayed diagnosis, dyspnea, relevant systemic involvement, and reduced FVC. On the basis of the analysis, a 3-letter scoring system (A, B and C) was developed according to the selected factors. The positive predictive values for persistent course for A (≤ 1 point) and C scores (≥ 4 points) were 12.5% and 81.8%, respectively.

CONCLUSIONS

A score can be derived by selected features at initial evaluation, allowing the prediction of outcomes in a significant number of sarcoidosis patients.

摘要

目的

确定在初次评估时与结节病病程相关的预测特征,并制定预测评分。

方法

这是一项回顾性研究,涉及肺结节病患者,根据疾病的自限性或持续性分为两类,通过单变量分析比较两组间结局数据。通过多变量分析选择与持续性疾病相关的特征,并设计预测评分。

结果

样本包括 200 例患者(平均年龄 49 岁)。症状到诊断的中位时间为 12 个月,43%的病例存在延迟诊断(>12 个月)。最常见的放射学分期为 II 期;37%的患者存在 FVC 降低。37%的患者存在明显的全身受累。在结节病诊断前,44 例患者曾接受过肺结核治疗。77%的患者需要接受结节病治疗,115 例患者的病程持续存在。排除 40 例纤维化患者后,与持续性疾病相关的预测因素包括实质受累、延迟诊断、呼吸困难、全身受累和 FVC 降低。在此基础上,根据所选因素制定了一个 3 字母评分系统(A、B 和 C)。A(≤1 分)和 C(≥4 分)评分的持续性疾病阳性预测值分别为 12.5%和 81.8%。

结论

在初次评估时,可以通过选择的特征得出评分,从而对大量结节病患者的预后进行预测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e5b/8836631/0a4b66ad8ed9/1806-3756-jbpneu-48-01-e20210366-gf3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e5b/8836631/816ed02a0bd5/1806-3756-jbpneu-48-01-e20210366-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e5b/8836631/ff54d68617c5/1806-3756-jbpneu-48-01-e20210366-gf2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e5b/8836631/0a4b66ad8ed9/1806-3756-jbpneu-48-01-e20210366-gf3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e5b/8836631/816ed02a0bd5/1806-3756-jbpneu-48-01-e20210366-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e5b/8836631/ff54d68617c5/1806-3756-jbpneu-48-01-e20210366-gf2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e5b/8836631/0a4b66ad8ed9/1806-3756-jbpneu-48-01-e20210366-gf3.jpg

相似文献

1
Prognostic features of sarcoidosis course in a Brazilian cohort.巴西队列中类肉瘤病病程的预后特征。
J Bras Pneumol. 2022 Feb 2;48(1):e20210366. doi: 10.36416/1806-3756/e20210366. eCollection 2022.
2
Predictive value of C-reactive protein and clinically relevant baseline variables in sarcoidosis.C反应蛋白及临床相关基线变量在结节病中的预测价值
Sarcoidosis Vasc Diffuse Lung Dis. 2016 Dec 23;33(4):331-340.
3
A new tool to assess sarcoidosis severity.一种评估结节病严重程度的新工具。
Chest. 2006 May;129(5):1234-45. doi: 10.1378/chest.129.5.1234.
4
Delayed diagnosis of sarcoidosis is common in Brazil.结节病的延迟诊断在巴西很常见。
J Bras Pneumol. 2013 Sep-Oct;39(5):539-46. doi: 10.1590/S1806-37132013000500003.
5
A novel multi-parameter scoring system for distinguishing sarcoidosis from sputum negative tuberculosis.一种用于鉴别结节病与痰菌阴性肺结核的新型多参数评分系统。
Sarcoidosis Vasc Diffuse Lung Dis. 2012 Mar;29(1):11-8.
6
Clinical features and outcomes of asymptomatic pulmonary sarcoidosis. A comparative cohort study.无症状肺结节病的临床特征和结局。一项对照队列研究。
Respir Med. 2020 Aug;169:105998. doi: 10.1016/j.rmed.2020.105998. Epub 2020 May 15.
7
Factor analysis of sarcoidosis phenotypes at two referral centers in Brazil.巴西两个转诊中心结节病表型的因子分析。
Sarcoidosis Vasc Diffuse Lung Dis. 2011 Jul;28(1):34-43.
8
Sarcoidosis diagnosed in elderly subjects: retrospective study of 30 cases.老年患者结节病的诊断:30例回顾性研究。
Chest. 2004 Nov;126(5):1423-30. doi: 10.1378/chest.126.5.1423.
9
[Sarcoidosis--diagnostics, prognosis and therapy. A retrospective analysis].[结节病——诊断、预后与治疗。一项回顾性分析]
Vnitr Lek. 2012 Oct;58(10):735-42.
10
Clinical features and prognostic significance of splenic involvement in sarcoidosis.结节病脾脏受累的临床特征及预后意义
Monaldi Arch Chest Dis. 2017 Dec 21;87(3):893. doi: 10.4081/monaldi.2017.893.

引用本文的文献

1
Cardiopulmonary exercise testing complements both spirometry and nuclear imaging for assessing sarcoidosis stage and for monitoring disease activity.心肺运动试验在评估结节病分期和监测疾病活动方面,对肺量计检查和核成像检查都起到补充作用。
Sarcoidosis Vasc Diffuse Lung Dis. 2024 Mar 26;41(1):e2024017. doi: 10.36141/svdld.v41i1.15125.
2
The ability to predict the clinical course of pulmonary sarcoidosis from data that is right in front of us.从我们眼前的数据预测结节病临床病程的能力。
J Bras Pneumol. 2022 Feb 2;48(1):e20220012. doi: 10.36416/1806-3756/e20220012.

本文引用的文献

1
Catch the rainbow: Prognostic factor of sarcoidosis.捕捉彩虹:结节病的预后因素。
Lung India. 2020 Sep-Oct;37(5):425-432. doi: 10.4103/lungindia.lungindia_380_19.
2
Outcome of pulmonary sarcoidosis: a population-based study 1976-2013.肺结节病的转归:一项基于人群的1976 - 2013年研究。
Sarcoidosis Vasc Diffuse Lung Dis. 2018;35(2):123-128. doi: 10.36141/svdld.v35i2.6356. Epub 2018 Apr 28.
3
Pulmonary Sarcoidosis: Prognostic Factors at Diagnosis in Patients from North of Portugal.葡萄牙北部患者肺结节病:诊断时的预后因素
Reumatol Clin (Engl Ed). 2020 Nov-Dec;16(6):468-472. doi: 10.1016/j.reuma.2018.10.004. Epub 2018 Dec 14.
4
Diagnostic Yield of Transbronchial Biopsy in Comparison to High Resolution Computerized Tomography in Sarcoidosis Cases.结节病病例中经支气管活检与高分辨率计算机断层扫描的诊断率比较
Asian Pac J Cancer Prev. 2018 Apr 25;19(4):1029-1033. doi: 10.22034/APJCP.2018.19.4.1029.
5
Strategies for identifying pulmonary sarcoidosis patients at risk for severe or chronic disease.识别有严重或慢性疾病风险的结节病患者的策略。
Expert Rev Respir Med. 2017 Feb;11(2):111-118. doi: 10.1080/17476348.2017.1281745. Epub 2017 Jan 20.
6
Refractory pulmonary sarcoidosis - proposal of a definition and recommendations for the diagnostic and therapeutic approach.难治性肺结节病——定义提案及诊断与治疗方法建议
Clin Pulm Med. 2016 Mar;23(2):67-75. doi: 10.1097/CPM.0000000000000136.
7
Features of sarcoidosis associated with chronic disease.结节病与慢性病相关的特征。
Sarcoidosis Vasc Diffuse Lung Dis. 2015 Jan 5;31(4):275-81.
8
The high frequency of healthcare use in patients one year prior to a sarcoidosis diagnosis.结节病诊断前一年患者的高医疗使用频率。
Sarcoidosis Vasc Diffuse Lung Dis. 2014 Oct 20;31(3):256-61.
9
The relationships among dyspnoea, health-related quality of life and psychological factors in sarcoidosis.结节病中呼吸困难、健康相关生活质量和心理因素之间的关系。
Respirology. 2014 Oct;19(7):1019-24. doi: 10.1111/resp.12359. Epub 2014 Aug 14.
10
Clinical phenotypes in sarcoidosis.结节病的临床表型。
Curr Opin Pulm Med. 2014 Sep;20(5):496-502. doi: 10.1097/MCP.0000000000000077.